Blacklisted Bliss GVS blames delayed re-registration for 'fake' drug issue in Ghana
This article was originally published in Scrip
Executive Summary
India's Bliss GVS Pharma, which has been blacklisted in Ghana following allegations of supplying a fake antimalarial there, has denied any quality concerns and blamed a delay in re-registration of its products for the regulatory agency's action.